Last reviewed · How we verify
NCT06241963
High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Refractory Epilepsy
NA trial testing Active Comparator: Unilateral real High definition transcranial direct current stimulation in Transcranial Direct Current Stimulation in 90 participants. Currently enrolling.
30 December 2025
Quick facts
| Lead sponsor | Anhui Medical University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 12 February 2024 |
| Primary completion | 30 December 2025 |
| Estimated completion | 30 June 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Active Comparator: Unilateral real High definition transcranial direct current stimulation
- Active Comparator: Bilateral real High definition transcranial direct current stimulation
- Sham Comparator: Sham High definition transcranial direct current stimulation
Conditions studied
- Transcranial Direct Current Stimulation — all drugs for Transcranial Direct Current Stimulation →
- EEG — all drugs for EEG →
- Functional Magnetic Resonance Imaging — all drugs for Functional Magnetic Resonance Imaging →
- Refractory Epilepsy — all drugs for Refractory Epilepsy →
Sponsor
Anhui Medical University
Who can join
Adults 18 to 50, any sex, with Transcranial Direct Current Stimulation or EEG. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To observe the clinical effect and safety of transcranial electrical stimulation on patients with refractory epilepsy before and after treatment and analyze its therapeutic mechanism.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06241963
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Transcranial Direct Current Stimulation
Currently open trials in the same condition.
- NCT06517706 — Brain Research and Integrative Neuroscience Network for COVID-19 · NA · recruiting
- NCT06556043 — Investigating the Effects of Transcranial Direct Current Stimulation to Different Brain Regions on Ankle Tracking Motor · NA · recruiting
- NCT06505460 — Exploring the Possible Beneficial Impact of Non-invasive and Invasive Neuromodulation on Freezing of Gait in Parkinson's · NA · recruiting
- NCT06121635 — The Effects of Two Types of t-DCS Stimulation on Robot-assisted Gait Training in Patients With Multiple Sclerosis · NA · active not recruiting
- NCT05492032 — Cumulative and Booster Effects of Multisession Prefrontal Transcranial Direct Current Stimulation in Adolescents With AS · NA · recruiting
Other Anhui Medical University trials
Trials by the same sponsor.
- NCT07403591 — Mapsd Dual-target cTBS (Auditory Cortex and M1) for Generalized Anxiety Disorder · NA · not yet recruiting
- NCT07112612 — Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer · not yet recruiting
- NCT07112599 — Study of Predicting Lymph Node Metastasis of High-risk Prostate Cancer by Artificial Intelligence Multi-omics Analysis · recruiting
- NCT07176468 — Personalized iTBS in Real-World Clinical Settings for Schizophrenia · NA · recruiting
- NCT07486804 — Effects of taVNS Combined With tACS on Adolescents With Non-Suicidal Self-Injury · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06241963 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Anhui Medical University
- Last refreshed: 20 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06241963.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing